| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1f477e136b61fbe77e84d6d418838da |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-924 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate |
1990-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c9dfd57e22dc933506458efd968dfc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de91c0d2b545c21abb44c8766724b51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3513153c3d9bfe73525952a638eb5a7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bcfc6098909f4bd5e546040cadcd9c0 |
| publicationDate |
1996-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0507854-B1 |
| titleOfInvention |
Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein |
| abstract |
Chromogenic derivatives of N-acetylneuraminic acid modified in the 4-position by eliminating the hydroxyl group, by replacing the hydroxyl group with fluorine, or by replacing the hydrogen of the hydroxyl group with methyl are used as substrates in colorimetric assays for human influenza neuraminidase activity in clinical specimens for the purpose of selectively diagnosing influenza infection. The substrates may exhibit different reactivity with the different types of influenza neuraminidases, thus enabling one to discern the specific type of influenza infection and prescribe appropriate treatment and/or supportive therapy therefor. |
| priorityDate |
1989-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |